Hone Health is taking a bigger step into healthcare.
What’s happening: The diagnostic-led longevity platform announced a $28M equity investment led by Jay-Z’s MarcyPen Capital Partners and $200M in growth financing from General Catalyst’s Customer Value Fund (CVF).
Adding to $33M raised last year, Hone will now enter PMOS, metabolic health, and autoimmune care while exploring clinical trials.
White glove. Hone combines diagnostics, AI interpretation, and physician-led programs for 200K patients. Connecting longitudinal insight to precision care, it’s adding diagnostics like full-body MRI, DEXA, heart CTs, and microbiome tests alongside peptide and GLP-1 prescriptions.
Entering concierge medicine, it’s launching an advanced membership analyzing 1.6K+ biomarkers.
White coat. Expanding beyond its roots in men’s health, CEO Saad Alam says the company is building a research platform to accelerate health outcomes, including for tough-to-treat hormonal conditions. Bought in, goop founder and Hone investor Gwyneth Paltrow believes it can take the once-niche wellness conversation mainstream.
Looking ahead: As consumer-led healthcare grows crowded, Hone is stacking specialties and pursuing science-supported outcomes to stand out.